Y10S 424/814
Viral vaccine for ovine species
Official title: Viral vaccine for ovine species, e.g. sheep
Y10S424/814 (Viral vaccine for ovine species) appears on 5 US grants and 1 published applications in this corpus.
Search patents in Y10S- Granted patents
- 5
- Published applications
- 1
- Assignees
- 4
- Inventors
- 10
- Latest grant
- 9 Dec 2003
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Broad spectrum antimicrobial compound and treatment9 Dec 2003US 6,660,262 B2Bovine Health Products, Inc.
- LH-RH receptor antagonists24 Oct 2000US 6,136,781 ATakeda Chemical Industries, Ltd.
- Vaccine for bluetongue disease employing platinum compounds24 Feb 1987US 4,645,666 AThe Regents of the University of California
- Psoralen inactivated double-stranded RNA viral vaccines8 Oct 1985US 4,545,987 AAdvanced Genetics Research Institute
- Method of protecting cattle and sheep against bovine leukemia virus and vaccines for use therein6 Apr 1982US 4,323,555 AThe Regents of the University of California
Most cited
By later US patents
- Psoralen inactivated double-stranded RNA viral vaccines23US 4,545,987 AAdvanced Genetics Research Institute · 1985
- Method of protecting cattle and sheep against bovine leukemia virus and vaccines for use therein9US 4,323,555 AThe Regents of the University of California · 1982
- Vaccine for bluetongue disease employing platinum compounds3US 4,645,666 AThe Regents of the University of California · 1987
- LH-RH receptor antagonists2US 6,136,781 ATakeda Chemical Industries, Ltd. · 2000
- Broad spectrum antimicrobial compound and treatment1US 6,660,262 B2Bovine Health Products, Inc. · 2003